Edition of Prostaglandin E2 Receptors EP2 and EP4 by CRISPR/Cas9 Technology in Equine Adipose Mesenchymal Stem Cells

In mesenchymal stem cells (MSCs), it has been reported that prostaglandin E2 (PGE2) stimulation of EP2 and EP4 receptors triggers processes such as migration, self-renewal, survival, and proliferation, and their activation is involved in homing. The aim of this work was to establish a genetically mo...

Full description

Bibliographic Details
Main Authors: Ana Carolina Furlanetto Mançanares, Joel Cabezas, José Manríquez, Vanessa Cristina de Oliveira, Yat Sen Wong Alvaro, Daniela Rojas, Felipe Navarrete Aguirre, Lleretny Rodriguez-Alvarez, Fidel Ovidio Castro
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Animals
Subjects:
Online Access:https://www.mdpi.com/2076-2615/10/6/1078
_version_ 1827714413251002368
author Ana Carolina Furlanetto Mançanares
Joel Cabezas
José Manríquez
Vanessa Cristina de Oliveira
Yat Sen Wong Alvaro
Daniela Rojas
Felipe Navarrete Aguirre
Lleretny Rodriguez-Alvarez
Fidel Ovidio Castro
author_facet Ana Carolina Furlanetto Mançanares
Joel Cabezas
José Manríquez
Vanessa Cristina de Oliveira
Yat Sen Wong Alvaro
Daniela Rojas
Felipe Navarrete Aguirre
Lleretny Rodriguez-Alvarez
Fidel Ovidio Castro
author_sort Ana Carolina Furlanetto Mançanares
collection DOAJ
description In mesenchymal stem cells (MSCs), it has been reported that prostaglandin E2 (PGE2) stimulation of EP2 and EP4 receptors triggers processes such as migration, self-renewal, survival, and proliferation, and their activation is involved in homing. The aim of this work was to establish a genetically modified adipose (aMSC) model in which receptor genes EP2 and EP4 were edited separately using the CRISPR/Cas9 system. After edition, the genes were evaluated as to if the expression of MSC surface markers was affected, as well as the migration capacity in vitro of the generated cells. Adipose MSCs were obtained from Chilean breed horses and cultured in DMEM High Glucose with 10% fetal bovine serum (FBS). sgRNA were cloned into a linearized LentiCRISPRv2GFP vector and transfected into HEK293FT cells for producing viral particles that were used to transduce aMSCs. GFP-expressing cells were separated by sorting to obtain individual clones. Genomic DNA was amplified, and the site-directed mutation frequency was assessed by T7E1, followed by Sanger sequencing. We selected 11 clones of EP2 and 10 clones of EP4, and by Sanger sequencing we confirmed 1 clone knock-out to aMSC/EP2 and one heterozygous mutant clone of aMSC/EP4. Both edited cells had decreased expression of EP2 and EP4 receptors when compared to the wild type, and the edition of EP2 and EP4 did not affect the expression of MSC surface markers, showing the same pattern in filling the scratch. We can conclude that the edition of these receptors in aMSCs does not affect their surface marker phenotype and migration ability when compared to wild-type cells.
first_indexed 2024-03-10T18:57:20Z
format Article
id doaj.art-7354a6f8427b4693b5a76b6fe1be6d86
institution Directory Open Access Journal
issn 2076-2615
language English
last_indexed 2024-03-10T18:57:20Z
publishDate 2020-06-01
publisher MDPI AG
record_format Article
series Animals
spelling doaj.art-7354a6f8427b4693b5a76b6fe1be6d862023-11-20T04:39:08ZengMDPI AGAnimals2076-26152020-06-01106107810.3390/ani10061078Edition of Prostaglandin E2 Receptors EP2 and EP4 by CRISPR/Cas9 Technology in Equine Adipose Mesenchymal Stem CellsAna Carolina Furlanetto Mançanares0Joel Cabezas1José Manríquez2Vanessa Cristina de Oliveira3Yat Sen Wong Alvaro4Daniela Rojas5Felipe Navarrete Aguirre6Lleretny Rodriguez-Alvarez7Fidel Ovidio Castro8Department of Animal Science, Faculty of Veterinary Science, Universidad de Concepción, Campus Chillan, Chillán 3780000, ChileDepartment of Animal Science, Faculty of Veterinary Science, Universidad de Concepción, Campus Chillan, Chillán 3780000, ChileDepartment of Animal Science, Faculty of Veterinary Science, Universidad de Concepción, Campus Chillan, Chillán 3780000, ChileDepartment of Veterinary Medicine, Faculty of Animal Science and Food Engineering, University of São Paulo, Pirassununga, São Paulo 13630-000, BrazilDepartment of Animal Science, Faculty of Veterinary Science, Universidad de Concepción, Campus Chillan, Chillán 3780000, ChileDepartment of Animal Pathology, Faculty of Veterinary Sciences, Universidad de Concepción, Campus Chillan, Chillán 3780000, ChileDepartment of Animal Science, Faculty of Veterinary Science, Universidad de Concepción, Campus Chillan, Chillán 3780000, ChileDepartment of Animal Science, Faculty of Veterinary Science, Universidad de Concepción, Campus Chillan, Chillán 3780000, ChileDepartment of Animal Science, Faculty of Veterinary Science, Universidad de Concepción, Campus Chillan, Chillán 3780000, ChileIn mesenchymal stem cells (MSCs), it has been reported that prostaglandin E2 (PGE2) stimulation of EP2 and EP4 receptors triggers processes such as migration, self-renewal, survival, and proliferation, and their activation is involved in homing. The aim of this work was to establish a genetically modified adipose (aMSC) model in which receptor genes EP2 and EP4 were edited separately using the CRISPR/Cas9 system. After edition, the genes were evaluated as to if the expression of MSC surface markers was affected, as well as the migration capacity in vitro of the generated cells. Adipose MSCs were obtained from Chilean breed horses and cultured in DMEM High Glucose with 10% fetal bovine serum (FBS). sgRNA were cloned into a linearized LentiCRISPRv2GFP vector and transfected into HEK293FT cells for producing viral particles that were used to transduce aMSCs. GFP-expressing cells were separated by sorting to obtain individual clones. Genomic DNA was amplified, and the site-directed mutation frequency was assessed by T7E1, followed by Sanger sequencing. We selected 11 clones of EP2 and 10 clones of EP4, and by Sanger sequencing we confirmed 1 clone knock-out to aMSC/EP2 and one heterozygous mutant clone of aMSC/EP4. Both edited cells had decreased expression of EP2 and EP4 receptors when compared to the wild type, and the edition of EP2 and EP4 did not affect the expression of MSC surface markers, showing the same pattern in filling the scratch. We can conclude that the edition of these receptors in aMSCs does not affect their surface marker phenotype and migration ability when compared to wild-type cells.https://www.mdpi.com/2076-2615/10/6/1078CRISPR/cas9prostaglandin E2adipose mesenchymal stem cellequine
spellingShingle Ana Carolina Furlanetto Mançanares
Joel Cabezas
José Manríquez
Vanessa Cristina de Oliveira
Yat Sen Wong Alvaro
Daniela Rojas
Felipe Navarrete Aguirre
Lleretny Rodriguez-Alvarez
Fidel Ovidio Castro
Edition of Prostaglandin E2 Receptors EP2 and EP4 by CRISPR/Cas9 Technology in Equine Adipose Mesenchymal Stem Cells
Animals
CRISPR/cas9
prostaglandin E2
adipose mesenchymal stem cell
equine
title Edition of Prostaglandin E2 Receptors EP2 and EP4 by CRISPR/Cas9 Technology in Equine Adipose Mesenchymal Stem Cells
title_full Edition of Prostaglandin E2 Receptors EP2 and EP4 by CRISPR/Cas9 Technology in Equine Adipose Mesenchymal Stem Cells
title_fullStr Edition of Prostaglandin E2 Receptors EP2 and EP4 by CRISPR/Cas9 Technology in Equine Adipose Mesenchymal Stem Cells
title_full_unstemmed Edition of Prostaglandin E2 Receptors EP2 and EP4 by CRISPR/Cas9 Technology in Equine Adipose Mesenchymal Stem Cells
title_short Edition of Prostaglandin E2 Receptors EP2 and EP4 by CRISPR/Cas9 Technology in Equine Adipose Mesenchymal Stem Cells
title_sort edition of prostaglandin e2 receptors ep2 and ep4 by crispr cas9 technology in equine adipose mesenchymal stem cells
topic CRISPR/cas9
prostaglandin E2
adipose mesenchymal stem cell
equine
url https://www.mdpi.com/2076-2615/10/6/1078
work_keys_str_mv AT anacarolinafurlanettomancanares editionofprostaglandine2receptorsep2andep4bycrisprcas9technologyinequineadiposemesenchymalstemcells
AT joelcabezas editionofprostaglandine2receptorsep2andep4bycrisprcas9technologyinequineadiposemesenchymalstemcells
AT josemanriquez editionofprostaglandine2receptorsep2andep4bycrisprcas9technologyinequineadiposemesenchymalstemcells
AT vanessacristinadeoliveira editionofprostaglandine2receptorsep2andep4bycrisprcas9technologyinequineadiposemesenchymalstemcells
AT yatsenwongalvaro editionofprostaglandine2receptorsep2andep4bycrisprcas9technologyinequineadiposemesenchymalstemcells
AT danielarojas editionofprostaglandine2receptorsep2andep4bycrisprcas9technologyinequineadiposemesenchymalstemcells
AT felipenavarreteaguirre editionofprostaglandine2receptorsep2andep4bycrisprcas9technologyinequineadiposemesenchymalstemcells
AT lleretnyrodriguezalvarez editionofprostaglandine2receptorsep2andep4bycrisprcas9technologyinequineadiposemesenchymalstemcells
AT fidelovidiocastro editionofprostaglandine2receptorsep2andep4bycrisprcas9technologyinequineadiposemesenchymalstemcells